Contribution: Industrial Research Assistance Program
Voxcell Bioinnovation Inc.
$500,000.00
Eurostars E!10963 – INTRINSIC: Intracellular Checkpoint Nanobodies in Vascularized 3D Cancer Models for Precision T cell Reactivation
FY 2026-27 · 2026-08-03
Summary
As part of the international consortium project “INTRINSIC: Intracellular Checkpoint Nanobodies in Vascularized 3D Cancer Models for Precision T cell Reactivation, this project will focus on developing and validating a vascularized three-dimensional non-small cell lung cancer tissue model with perfusable human microvasculature to evaluate a novel immunotherapy.
Department
Program
Industrial Research Assistance Program
Recipient
Location
Victoria|Victoria, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
719330532
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2027-11-30
Agreement Number
1046159
Agreement Start Date
2026-08-03
Agreement Title
Eurostars E!10963 – INTRINSIC: Intracellular Checkpoint Nanobodies in Vascularized 3D Cancer Models for Precision T cell Reactivation
Agreement Title (French)
Eurostars E!10963 – INTRINSIC : Nanocorps ciblant les points de contrôle intracellulaires dans des modèles cancéreux 3D vascularisés pour une réactivation de précision des lymphocytes T
Agreement Type
Contribution
Agreement Value
$500,000.00
Amendment Number
0
Coverage
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity. | Les projets du Programme d'aide à la recherche industrielle favorisent la création de richesse au Canada grâce à l'innovation technologique et renforcent l'écosystème canadien de l'innovation en créant de nouvelles capacités industrielles.
Description
As part of the international consortium project “INTRINSIC: Intracellular Checkpoint Nanobodies in Vascularized 3D Cancer Models for Precision T cell Reactivation, this project will focus on developing and validating a vascularized three-dimensional non-small cell lung cancer tissue model with perfusable human microvasculature to evaluate a novel immunotherapy.
Description (French)
Dans le cadre du projet de consortium international « INTRINSIC : Nanocorps ciblant les points de contrôle intracellulaires dans des modèles cancéreux 3D vascularisés pour une réactivation de précision des lymphocytes T », ce projet sera axé sur le développement et la validation d’un modèle tissulaire tridimensionnel vascularisé de cancer du poumon non à petites cellules, doté d’une microvascularisation humaine perfusible, afin d’évaluer une nouvelle immunothérapie.
Expected Results
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Expected Results (French)
Les résultats attendus du Programme d’aide à la recherche industrielle du CNRC sont axés sur la croissance des petites et moyennes entreprises (PME) grâce à l’innovation et à la création de richesse pour le Canada.
Federal Riding
Victoria
Federal Riding (French)
Victoria
Federal Riding Number
59042
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program
Program Name (French)
Programme d’aide à la recherche industrielle
Program Purpose
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Program Purpose (French)
Les contributions versées aux entreprises en vertu du Programme d’aide à la recherche industrielle ont pour objectif d’apporter un soutien aux petites et moyennes entreprises (PME) afin qu’elles puissent approfondir leurs connaissances en matière d’innovation et renforcer leur capacité d’innovation, de croissance et de création de richesse pour le Canada.
Recipient Business Number
719330532
Recipient City
Victoria|Victoria
Recipient Country
CA
Recipient Legal Name
Voxcell Bioinnovation Inc.
Recipient Operating Name
VoxCell
Recipient Postal Code
V8T 5L2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2026-2027-Q2-1046159
